Home Page
23:16:21 EDT Wed 28 Sep 2016
Enter Symbol
or Name
USA
CA



Z:SNY - SANOFI - http://www.sanofi-aventis.com23:16:21 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
SNY - Z1.038.41 · 41.000.338.67+0.521.44,945.0171,4278,88838.395  38.69  38.1951.88  37.4117:16:51Sep 2615 min RT 2¢

Recent Trades - Last 10 of 8888
Time ETExPriceChangeVolume
17:16:51Z38.22840.078438,610
16:41:45Z38.670.52900
16:41:45Z38.670.52100
16:18:12Z38.5580.40868,000
16:17:53Z38.5580.40868,000
16:03:49Z38.670.52299,480
15:59:55Z38.640.49200
15:59:55Z38.650.50500
15:59:55Z38.650.50100
15:59:55Z38.650.50200

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2016-09-26 01:00SNYNews ReleaseRegeneron and Sanofi Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA
2016-09-16 10:30SNYNews ReleaseTreatment Effects Maintained Over Six Years in Patients with Relapsing Remitting Multiple Sclerosis who Received Sanofi Genzyme ’s Lemtrada ® (alemtuzumab) in Clinical Trials
2016-09-15 10:45SNYNews ReleaseResults from 1,000-Patient, Global Real-World Patient-Reported Outcomes Study of Sanofi Genzyme ’s Aubagio ® (teriflunomide) in Patients with Relapsing Multiple Sclerosis Demonstrate High Levels of Treatment Satisfaction
2016-09-12 08:04SNYNews ReleaseSanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform